Inhibitory Effects of Periplocin on Lymphoma Cells: A Network Pharmacology Approach and Experimental Validation

References

• BrayF, FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• TerasLR, DeSantisCE, CerhanJR, MortonLM, JemalA, FlowersCR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66(6):443–459. doi:10.3322/caac.2135727618563
   PubMed Web of Science ®Google Scholar
• ChenW, ZhengR, BaadePD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• ConnorsJM, CozenW, SteidlC, et al. Hodgkin lymphoma. Nat Rev Dis Primers. 2020;6(1):61.32703953
   PubMed Web of Science ®Google Scholar
• HewardJA, KumarEA, KorfiK, OkosunJ, FitzgibbonJ. Precision medicine and lymphoma. Curr Opin Hematol. 2018;25(4):329–334. doi:10.1097/MOH.000000000000043729738334
   PubMed Web of Science ®Google Scholar
• ArmitageJO, GascoyneRD, LunningMA, CavalliF. Non-Hodgkin lymphoma. Lancet. 2017;390(10091):298–310. doi:10.1016/S0140-6736(16)32407-228153383
   PubMed Web of Science ®Google Scholar
• MugnainiEN, GhoshN. Lymphoma. Prim Care. 2016;43(4):661–675. doi:10.1016/j.pop.2016.07.01227866584
   PubMed Web of Science ®Google Scholar
• GodfreyJ, LeukamMJ, SmithSM. An update in treating transformed lymphoma. Best Pract Res Clin Haematol. 2018;31(3):251–261. doi:10.1016/j.beha.2018.07.00830213394
   PubMed Web of Science ®Google Scholar
• LiA, GuoX, XieJ, et al. Validation of biomarkers in cardiotoxicity induced by Periplocin on neonatal rat cardiomyocytes using UPLC-Q-TOF/MS combined with a support vector machine. J Pharm Biomed Anal. 2016;123(10):179–185. doi:10.1016/j.jpba.2016.02.01426924293
   PubMed Web of Science ®Google Scholar
• LiL, ZhaoLM, DaiSL, et al. Periplocin extracted from cortex periplocae induced apoptosis of gastric cancer cells via the ERK1/2-EGR1 pathway. Cell Physiol Biochem. 2016;38(5):1939–1951. doi:10.1159/00044555527160973
   PubMedGoogle Scholar
• LohbergerB, BernhartE, StuendlN, et al. Periplocin mediates TRAIL-induced apoptosis and cell cycle arrest in human myxofibrosarcoma cells via the ERK/p38/JNK pathway. Phytomedicine. 2020;76:153262. doi:10.1016/j.phymed.2020.15326232559583
   PubMed Web of Science ®Google Scholar
• LohbergerB, WagnerS, WohlmutherJ, et al. Periplocin, the most anti-proliferative constituent of Periploca sepium, specifically kills liposarcoma cells by death receptor mediated apoptosis. Phytomedicine. 2018;51(1):162–170. doi:10.1016/j.phymed.2018.10.00830466613
   PubMed Web of Science ®Google Scholar
• LuZJ, ZhouY, SongQ, et al. Periplocin inhibits growth of lung cancer in vitro and in vivo by blocking AKT/ERK signaling pathways. Cell Physiol Biochem. 2010;26(4–5):609–618. doi:10.1159/00032232821063098
   PubMed Web of Science ®Google Scholar
• ZhaoL, ShanB, DuY, WangM, LiuL, RenF. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling. Oncol Rep. 2010;24(2):375–383.20596624
   PubMed Web of Science ®Google Scholar
• ZhaoLM, LiL, HuangY, et al. Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway. Mol Carcinog. 2019;58(6):1033–1045. doi:10.1002/mc.2299130737960
   PubMed Web of Science ®Google Scholar
• HanL, DaiS, LiZ, et al. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: implication in anticancer therapy. J Exp Clin Cancer Res. 2019;38(1):501. doi:10.1186/s13046-019-1498-z31864387
   PubMed Web of Science ®Google Scholar
• BardouP, MarietteJ, EscudiéF, DjemielC, KloppC. jvenn: an interactive Venn diagram viewer. BMC Bioinform. 2014;15(1):293. doi:10.1186/1471-2105-15-293
   PubMed Web of Science ®Google Scholar
• KanehisaM, SatoY. KEGG Mapper for inferring cellular functions from protein sequences. Protein Sci. 2020;29(1):28–35. doi:10.1002/pro.371131423653
   PubMed Web of Science ®Google Scholar
• ChengCF, LuIH, TsengHW, et al. Antitumor effect of periplocin in TRAIL-resistant human hepatocellular carcinoma cells through downregulation of IAPs. Evid Based Complement Alternat Med. 2013;2013:958025. doi:10.1155/2013/95802523365613
   PubMed Web of Science ®Google Scholar
• LuZ, SongQ, YangJ, et al. Comparative proteomic analysis of anti-cancer mechanism by periplocin treatment in lung cancer cells. Cell Physiol Biochem. 2014;33(3):859–868. doi:10.1159/00035865824685647
   PubMedGoogle Scholar
• BloiseE, BracaA, De TommasiN, BelisarioMA. Pro-apoptotic and cytostatic activity of naturally occurring cardenolides. Cancer Chemother Pharmacol. 2009;64(4):793–802. doi:10.1007/s00280-009-0929-519184018
   PubMed Web of Science ®Google Scholar
• ZhangX, NanH, GuoJ, YangS, LiuJ. Periplocin induces apoptosis and inhibits inflammation in rheumatoid arthritis fibroblast-like synoviocytes via nuclear factor kappa B pathway. IUBMB Life. 2020;72(9):1951–1959. doi:10.1002/iub.232832584515
   PubMed Web of Science ®Google Scholar
• WangXY, GaoXM, LiuH, et al. Gene expression profiling of the proliferative effect of periplocin on mouse cardiac microvascular endothelial cells. Chin J Integr Med. 2010;16(1):33–40. doi:10.1007/s11655-010-0033-z20131034
   PubMed Web of Science ®Google Scholar
• ChenL, JiangP, LiJ, et al. Periplocin promotes wound healing through the activation of Src/ERK and PI3K/Akt pathways mediated by Na/K-ATPase. Phytomedicine. 2019;57:72–83. doi:10.1016/j.phymed.2018.12.01530668325
   PubMed Web of Science ®Google Scholar